Mo Cheng

505 total citations
22 papers, 376 citations indexed

About

Mo Cheng is a scholar working on Surgery, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mo Cheng has authored 22 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Pathology and Forensic Medicine and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mo Cheng's work include Sarcoma Diagnosis and Treatment (5 papers), Spine and Intervertebral Disc Pathology (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Mo Cheng is often cited by papers focused on Sarcoma Diagnosis and Treatment (5 papers), Spine and Intervertebral Disc Pathology (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Mo Cheng collaborates with scholars based in China, Sweden and United States. Mo Cheng's co-authors include Wending Huang, Wangjun Yan, Wei Xu, Jianru Xiao, Wangjun Yan, Weiluo Cai, Huabin Yin, Jing Wang, Tong Meng and Meng Fang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Chemical Engineering Journal.

In The Last Decade

Mo Cheng

19 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mo Cheng China 11 121 103 102 101 81 22 376
Masataka Uehara Japan 13 231 1.9× 132 1.3× 168 1.6× 42 0.4× 99 1.2× 44 532
Buhua Sun China 10 54 0.4× 138 1.3× 56 0.5× 77 0.8× 101 1.2× 20 355
Yasutaka Murahashi Japan 13 121 1.0× 79 0.8× 64 0.6× 198 2.0× 56 0.7× 54 462
Thomas Cordonnier France 11 135 1.1× 219 2.1× 154 1.5× 22 0.2× 74 0.9× 15 532
Qin Shi China 12 49 0.4× 82 0.8× 64 0.6× 66 0.7× 63 0.8× 38 523
Emmanuelle David France 8 109 0.9× 252 2.4× 145 1.4× 108 1.1× 62 0.8× 15 633
Xiaohua Ban China 10 82 0.7× 77 0.7× 176 1.7× 19 0.2× 43 0.5× 26 406
Noah S. Nelson United States 14 153 1.3× 93 0.9× 95 0.9× 30 0.3× 70 0.9× 55 539
Elizabeth E. Smith United States 12 90 0.7× 114 1.1× 165 1.6× 73 0.7× 36 0.4× 21 494
Lin Cui United Kingdom 8 46 0.4× 111 1.1× 49 0.5× 61 0.6× 55 0.7× 14 367

Countries citing papers authored by Mo Cheng

Since Specialization
Citations

This map shows the geographic impact of Mo Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mo Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mo Cheng more than expected).

Fields of papers citing papers by Mo Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mo Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mo Cheng. The network helps show where Mo Cheng may publish in the future.

Co-authorship network of co-authors of Mo Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Mo Cheng. A scholar is included among the top collaborators of Mo Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mo Cheng. Mo Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yang, Xin Zhou, Hossein Ghanizadeh, et al.. (2025). Structural Insights Into the Role of RxLR Effectors in the Arms Race Between Oomycetes and Plants. Molecular Plant Pathology. 26(9). e70138–e70138.
2.
Cheng, Mo, Qing‐Jie Kong, Qing Tian, et al.. (2024). Osteosarcoma-targeted Cu and Ce based oxide nanoplatform for NIR II fluorescence/magnetic resonance dual-mode imaging and ros cascade amplification along with immunotherapy. Journal of Nanobiotechnology. 22(1). 151–151. 8 indexed citations
3.
Li, Wenke, Jing Wei, Mo Cheng, & Ming Liu. (2024). Unveiling promising targets in gastric cancer therapy: A comprehensive review. SHILAP Revista de lepidopterología. 32(3). 200857–200857. 6 indexed citations
4.
Huang, Wending, Weiluo Cai, Mo Cheng, et al.. (2024). Soft-tissue reconstruction with pedicled vertical rectus abdominis myocutaneous flap after total or high sacrectomy for giant sacral tumor. Journal of Plastic Reconstructive & Aesthetic Surgery. 91. 173–180.
5.
Hu, Xianglin, Hongrun Wu, Yani Kang, et al.. (2024). Establishing patient-derived tumor organoids of bone metastasis from lung adenocarcinoma reveals the transcriptomic changes underlying denosumab treatment. Clinical & Experimental Metastasis. 42(1). 8–8. 3 indexed citations
6.
Cai, Weiluo, Mo Cheng, Yi Wang, et al.. (2023). Prediction and related genes of cancer distant metastasis based on deep learning. Computers in Biology and Medicine. 168. 107664–107664. 8 indexed citations
7.
Hu, Xianglin, Sean M. Barber, Weiluo Cai, et al.. (2023). Implant failure and revision strategies after total spondylectomy for spinal tumors. Journal of bone oncology. 42. 100497–100497. 2 indexed citations
8.
Fang, Meng, Minchao Liu, Mo Cheng, et al.. (2023). Asymmetric Mesoporous Nanoformulation for Combination Treatment of Soft Tissue Sarcoma. ACS Materials Letters. 5(3). 811–821. 12 indexed citations
9.
Sun, Zhengwang, Mengchen Yin, Yue‐Li Sun, et al.. (2022). Customized Multilevel 3D Printing Implant for Reconstructing Spine Tumor: A Retrospective Case Series Study in a Single Center. Orthopaedic Surgery. 14(9). 2016–2022. 11 indexed citations
10.
Kenan, Shachar, et al.. (2022). 3D-Printed Patient-Customized Artificial Vertebral Body for Spinal Reconstruction after Total En Bloc Spondylectomy of Complex Multi-Level Spinal Tumors. International Journal of Bioprinting. 8(3). 576–576. 18 indexed citations
11.
Luo, Guanghong, Zihuang Li, Gang Xu, et al.. (2022). Three-staged tumor inhibition by mitochondria-targeted cascaded gas/mild-photothermal/photodynamic synergistic therapy. Chemical Engineering Journal. 442. 136169–136169. 19 indexed citations
13.
Huang, Wending, Weiluo Cai, Mo Cheng, et al.. (2022). Freehand S2‐Alar‐Iliac Screw Placement Technique in Lumbosacral Spinal Tumors: A Preliminary Study. Orthopaedic Surgery. 14(9). 2195–2202.
14.
Huang, Wending, Weiluo Cai, Zhengwang Sun, et al.. (2021). Comparison of Surgical Outcomes Between Separation Surgery and Piecemeal Spondylectomy for Spinal Metastasis: A Retrospective Analysis. Frontiers in Surgery. 8. 686930–686930. 7 indexed citations
15.
Cheng, Mo, Wending Huang, Weiluo Cai, et al.. (2019). Growth hormone receptor promotes osteosarcoma cell growth and metastases. FEBS Open Bio. 10(1). 127–134. 9 indexed citations
16.
Cheng, Mo, Weiluo Cai, Wending Huang, et al.. (2018). Histone deacetylase 6 regulated expression of IL-8 is involved in the doxorubicin (Dox) resistance of osteosarcoma cells via modulating ABCB1 transcription. European Journal of Pharmacology. 840. 1–8. 18 indexed citations
17.
Xu, Wei, Zhou Wang, Mo Cheng, et al.. (2017). Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma. Scientific Reports. 7(1). 40446–40446. 72 indexed citations
18.
Yin, Huabin, Mo Cheng, Bo Li, et al.. (2015). Treatment and outcome of malignant giant cell tumor in the spine. Journal of Neuro-Oncology. 124(2). 275–281. 17 indexed citations
19.
Meng, Tong, Huabin Yin, Bo Li, et al.. (2014). Clinical features and prognostic factors of patients with chordoma in the spine: a retrospective analysis of 153 patients in a single center. Neuro-Oncology. 17(5). 725–732. 69 indexed citations
20.
Huang, Quan, Zhengyu Jiang, Tong Meng, et al.. (2014). MiR-30a inhibits osteolysis by targeting RunX2 in giant cell tumor of bone. Biochemical and Biophysical Research Communications. 453(1). 160–165. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026